Loading…
for educational and safety purposes
Ezetimibe and Bempedoic Acid both come up in the same conversations. Ezetimibe: Ezetimibe is a cholesterol absorption inhibitor used to lower blood cholesterol, most often alongside a statin. Bempedoic Acid: Bempedoic acid is an oral cholesterol-lowering drug and the first of a class that inhibits the enzyme ATP-citrate lyase, sold under brand names such as Nexletol and Nilemdo.
Ezetimibe is a cholesterol absorption inhibitor used to lower blood cholesterol, most often alongside a statin. Sold under the brand name Zetia among others, it acts in the small intestine to block the transport protein that ferries dietary and biliary cholesterol into the body. It is taken as an oral tablet for high cholesterol and related lipid disorders.
Bempedoic acid is an oral cholesterol-lowering drug and the first of a class that inhibits the enzyme ATP-citrate lyase, sold under brand names such as Nexletol and Nilemdo. It reduces LDL cholesterol by curbing cholesterol production in the liver, and because it is activated only in the liver and not in muscle, it tends to cause fewer muscle complaints than statins, which makes it useful for people who cannot tolerate statins. A large outcomes trial showed it lowers the risk of cardiovascular events, and it is also sold combined with ezetimibe.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
blocks
inhibits
inhibits
activates
modulates
activates
inhibits
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.